Tissue engineering a small diameter vessel substitute: Engineering constructs with select biomaterials and cells

Current Vascular Pharmacology

Volumn 10, Issue 3, 2012, Pages 347-360

  McBane, Joanne E ^a,b,c,d   Sharifpoor, Soroor ^a,b   Labow, Rosalind S ^c,d   Ruel, Marc ^c,d   Suuronen, Erik J ^c,d   Santerre, J Paul ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Extracellular matrix proteins; Monocytes; Natural biomaterials; Progenitor cells; Small caliber vessel; Stem cells; Synthetic biomaterials; Vascular tissue engineering

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ALPHA ACTIN; BIOMATERIAL; CALPONIN; CD31 ANTIGEN; CHITOSAN; COLLAGEN; DACRON; DESMIN; ELASTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; MYOSIN; POLITEF; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; POLYURETHAN; TISSUE SCAFFOLD; TRANSGELIN; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ADVENTITIA; BIOCOMPATIBILITY; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL DIAMETER; BLOOD VESSEL GRAFT; CARDIOVASCULAR DISEASE; CELL INTERACTION; CELL REGENERATION; COMPOSITE GRAFT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; EXTRACORPOREAL CIRCULATION; FIBROBLAST; HUMAN; HYDROGEL; MACROPHAGE; MONOCYTE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; TENSILE STRENGTH; TISSUE ENGINEERING; TUNICA MEDIA; UMBILICAL CORD; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR DISEASES; EXTRACELLULAR MATRIX; HUMANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84860264279     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016112799959378     Document Type: Review

References (187)

1. Causes of Death. Statistics Canada, 2004.
2. Economic Burden of Illness in Canada. Public Health Agency of Canada, 1998.
3. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2007; 115: e69-171.
4. Chlupac J, Filova E, Bacakova L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res 2009; 58 (Suppl 2): S119-39.
5. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 2005; 74: 570-81.
6. Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg 2005; 41: 349-54.
7. Jankowski RJ, Wagner WR. Directions in cardiovascular tissue engineering. Clin Plast Surg 1999; 26: 605-16, ix.
8. Isenberg BC, Williams C, Tranquillo RT. Small-diameter artificial arteries engineered in vitro. Circ Res 2006; 98: 25-35.
9. Mitchell SL, Niklason LE. Requirements for growing tissueengineered vascular grafts. Cardiovasc Pathol 2003; 12: 59-64.
10. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Blood vessels and endothelial cells. In: Gibbs S, Ed. Molecular Biology of the Cell. New York: Garland Science 2002; pp. 1279-83.
11. Pankajakshan D, Agrawal DK. Scaffolds in tissue engineering of blood vessels. Can J Physiol Pharmacol 2010; 88: 855-73.
12. Rotmans JI, Velema E, Verhagen HJ, et al. Rapid, arteriovenous graft failure due to intimal hyperplasia: a porcine, bilateral, carotid arteriovenous graft model. J Surg Res 2003; 113: 161-71.
13. Gao J, Crapo P, Nerem R, Wang Y. Co-expression of elastin and collagen leads to highly compliant engineered blood vessels. J Biomed Mater Res A 2008; 85: 1120-8.
14. Sarkar S, Salacinski HJ, Hamilton G, Seifalian AM. The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency. Eur J Vasc Endovasc Surg 2006; 31: 627-36.
15. Konig G, McAllister TN, Dusserre N, et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 2009; 30: 1542-50.
16. Girton TS, Oegema TR, Grassl ED, Isenberg BC, Tranquillo RT. Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. J Biomech Eng 2000; 122: 216-23.
17. Iwasaki K, Kojima K, Kodama S, et al. Bioengineered threelayered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 2008; 118: S52-7.
18. van Andel CJ, Pistecky PV, Borst C. Mechanical properties of porcine and human arteries: implications for coronary anastomotic connectors. Ann Thorac Surg 2003; 76: 58-64; discussion 64-5.
19. Soletti L, Hong Y, Guan J, et al. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater 2010; 6: 110-22.
20. L'Heureux N, Dusserre N, Konig G, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-5.
21. Havelka GE, Kibbe MR. The vascular adventitia: its role in the arterial injury response. Vasc Endovascular Surg 2011; 45: 381-90.
22. Tieu BC, Ju X, Lee C, et al. Aortic adventitial fibroblasts participate in Angiotensin-induced vascular wall inflammation and remodeling. J Vasc Res 2011; 48: 261-72.
23. Absher M, Woodcock-Mitchell J, Mitchell J, Baldor L, Low R, Warshaw D. Characterization of vascular smooth muscle cell phenotype in long-term culture. In Vitro Cell Dev Biol 1989; 25: 183-92.
24. Weissberg PL, Cary NR, Shanahan CM. Gene expression and vascular smooth muscle cell phenotype. Blood Press Suppl 1995; 2: 68-73.
25. Rovner AS, Murphy RA, Owens GK. Expression of smooth muscle and non-muscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem 1986; 261: 14740-5.
26. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-60.
27. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99: 2034-40.
28. Martin-Padura I, De Castellarnau C, Uccini S, et al. Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. The Journal of pathology 1995; 175: 51-7.
29. Forstermann U, Mugge A, Bode SM, Frolich JC. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res 1988; 63: 306-12.
30. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008; 20: 86-100.
31. Hong Y, Guan J, Fujimoto KL, Hashizume R, Pelinescu AL, Wagner WR. Tailoring the degradation kinetics of poly(ester carbonate urethane)urea thermoplastic elastomers for tissue engineering scaffolds. Biomaterials 2010; 31: 4249-58.
32. Santerre JP, Woodhouse K, Laroche G, Labow RS. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials 2005; 26: 7457-70.
33. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T. Technology insight: the evolution of tissueengineered vascular grafts--from research to clinical practice. Nat Clin Pract Cardiovasc Med 2007; 4: 389-95.
34. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.
35. Schutte RJ, Parisi-Amon A, Reichert WM. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 2009; 88: 128-39.
36. Schutte RJ, Xie L, Klitzman B, Reichert WM. In vivo cytokineassociated responses to biomaterials. Biomaterials 2009; 30: 160-8.
37. Kou PM, Babensee JE. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A 2010; 96: 239-60.
38. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009; 30: 1482-91.
39. Daniel J, Abe K, McFetridge PS. Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. Asaio J 2005; 51: 252-61.
40. Derham C, Yow H, Ingram J, et al. Tissue engineering smalldiameter vascular grafts: preparation of a biocompatible porcine ureteric scaffold. Tissue Eng Part A 2008; 14: 1871-82.
41. Narita Y, Kagami H, Matsunuma H, Murase Y, Ueda M, Ueda Y. Decellularized ureter for tissue-engineered small-caliber vascular graft. J Artif Organs 2008; 11: 91-9.
42. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.
43. Zhang P, Ruel M, Suuronen EJ. Collagen biomaterials for cardiac tissue engineering applications. In: Barnes SJ, Harris LP, Eds. Tissue Engineering: Roles, Materials and Applications: Nova Science Publishers, Inc. 2008; pp. 67-82.
44. Lepidi S, Grego F, Vindigni V, et al. Hyaluronan biodegradable scaffold for small-caliber artery grafting: preliminary results in an animal model. Eur J Vasc Endovasc Surg 2006; 32: 411-7.
45. Zhang L, Ao Q, Wang A, et al. A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering. J Biomed Mater Res A 2006; 77: 277-84.
46. Knox G, West JP. Dacron grafts in the treatment of arteriosclerotic occlusion of the superficial femoral artery; report of seven cases. Ann Surg 1957; 145: 59-67.
47. Soyer T, Lempinen M, Cooper P, Norton L, Eiseman B. A new venous prosthesis. Surgery 1972; 72: 864-72.
48. Norton L, Eiseman B. Replacement of portal vein during pancreatectomy for carcinoma. Surgery 1975; 77: 280-4.
49. Nishibe T, Kondo Y, Muto A, Dardik A. Optimal prosthetic graft design for small diameter vascular grafts. Vascular 2007; 15: 356-60.
50. Jeong SI, Kim SY, Cho SK, et al. Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors. Biomaterials 2007; 28: 1115-22.
51. Miller DC, Thapa A, Haberstroh KM, Webster TJ. Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials 2004; 25: 53-61.
52. Sarkar S, Isenberg BC, Hodis E, Leach JB, Desai TA, Wong JY. Fabrication of a layered microstructured polycaprolactone construct for 3-D tissue engineering. J Biomater Sci Polym Ed 2008; 19: 1347-62.
53. Ishii Y, Sakamoto S, Kronengold RT, et al. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J Thorac Cardiovasc Surg 2008; 135: 1237-45; discussion 45-6.
54. Grenier S, Sandig M, Mequanint K. Polyurethane biomaterials for fabricating 3D porous scaffolds and supporting vascular cells. J Biomed Mater Res A 2007; 82: 802-9.
55. Sharifpoor S, Labow RS, Santerre JP. Synthesis and characterization of degradable polar hydrophobic ionic polyurethane scaffolds for vascular tissue engineering applications. Biomacromolecules 2009; 10: 2729-39.
56. Guan J, Fujimoto KL, Sacks MS, Wagner WR. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials 2005; 26: 3961-71.
57. Watanabe T, Kanda K, Ishibashi-Ueda H, Yaku H, Nakayama Y. Development of biotube vascular grafts incorporating cuffs for easy implantation. J Artif Organs 2007; 10: 10-5.
58. Zhang L, Zhou J, Lu Q, Wei Y, Hu S. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds. Biotechnol Bioeng 2008; 99: 1007-15.
59. Alobaid N, Salacinski HJ, Sales KM, et al. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur J Vasc Endovasc Surg 2006; 32: 76-83.
60. Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA 2010; 107: 4669-74.
61. Sreerekha PR, Krishnan LK. Cultivation of endothelial progenitor cells on fibrin matrix and layering on dacron/ polytetrafluoroethylene vascular grafts. Artif organs 2006; 30: 242-9.
62. Aper T, Teebken OE, Steinhoff G, Haverich A. Use of a fibrin preparation in the engineering of a vascular graft model. Eur J Vasc Endovasc Surg 2004; 28: 296-302.
63. Lee SH, Moon JJ, Miller JS, West JL. Poly(ethylene glycol) hydrogels conjugated with a collagenase-sensitive fluorogenic substrate to visualize collagenase activity during three-dimensional cell migration. Biomaterials 2007; 28: 3163-70.
64. Lee SH, Moon JJ, West JL. Three-dimensional micropatterning of bioactive hydrogels via two-photon laser scanning photolithography for guided 3D cell migration. Biomaterials 2008; 29: 2962-8.
65. Kim WS, Seo JW, Rho JR, Kim WG. Histopathologic changes of acellularized xenogenic carotid vascular grafts implanted in a pigto-goat model. Int J Artif Organs 2007; 30: 44-52.
66. Ketchedjian A, Kreuger P, Lukoff H, et al. Ovine panel reactive antibody assay of HLA responsivity to allograft bioengineered vascular scaffolds. J Thorac Cardiovasc Surg 2005; 129: 159-66.
67. Schaner PJ, Martin ND, Tulenko TN, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004; 40: 146-53.
68. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006; 27: 3675-83.
69. Borschel GH, Huang YC, Calve S, et al. Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng 2005; 11: 778-86.
70. Noah EM, Chen J, Jiao X, Heschel I, Pallua N. Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. Biomaterials 2002; 23: 2855-61.
71. Walles T, Herden T, Haverich A, Mertsching H. Influence of scaffold thickness and scaffold composition on bioartificial graft survival. Biomaterials 2003; 24: 1233-9.
72. Jay SM, Shepherd BR, Bertram JP, Pober JS, Saltzman WM. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J 2008; 22: 2949-56.
73. Suzuki T, Ishii I, Kotani A, et al. Growth inhibition and differentiation of cultured smooth muscle cells depend on cellular crossbridges across the tubular lumen of type I collagen matrix honeycombs. Microvasc Res 2009; 77: 143-9.
74. Zeltinger J, Sherwood JK, Graham DA, Mueller R, Griffith LG. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng 2001; 7: 557-72.
75. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science 1999; 284: 489-93.
76. Hsu SH, Tseng HJ, Fang ZK. Polyurethane blended with polylactides for improved cell adhesion and reduced platelet activation. Artif Organs 1999; 23: 958-61.
77. Lee SH, Kim BS, Kim SH, et al. Elastic biodegradable poly(glycolide-co-caprolactone) scaffold for tissue engineering. J Biomed Mater Res A 2003; 66: 29-37.
78. Stitzel J, Liu J, Lee SJ, et al. Controlled fabrication of a biological vascular substitute. Biomaterials 2006; 27: 1088-94.
79. Wen SJ, Zhao LM, Li P, et al. Blood vessel tissue engineering: seeding vascular smooth muscle cells and endothelial cells sequentially on biodegradable scaffold in vitro. Zhonghua Yi Xue Za Zhi 2005; 85: 816-8.
80. Fuchs S, Ghanaati S, Orth C, et al. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 2009; 30: 526-34.
81. Giavaresi G, Tschon M, Daly JH, et al. In vitro and in vivo response to nanotopographically-modified surfaces of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and polycaprolactone. J Biomater Sci Polym Ed 2006; 17: 1405-23.
82. Ma Z, He W, Yong T, Ramakrishna S. Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell Orientation. Tissue Eng 2005; 11: 1149-58.
83. Serrano MC, Pagani R, Ameer GA, Vallet-Regi M, Portoles MT. Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(epsilon-caprolactone) films. J Biomed Mater Res A 2008; 87: 964-71.
84. Venugopal J, Ma LL, Yong T, Ramakrishna S. In vitro study of smooth muscle cells on polycaprolactone and collagen nanofibrous matrices. Cell Biol Int 2005; 29: 861-7.
85. Williamson MR, Black R, Kielty C. PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials 2006; 27: 3608-16.
86. Hsu SH, Sun SH, Chen DC. Improved retention of endothelial cells seeded on polyurethane small-diameter vascular grafts modified by a recombinant RGD-containing protein. Artif Organs 2003; 27: 1068-78.
87. Hsu SH, Tsai IJ, Lin DJ, Chen DC. The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. Med Eng Phys 2005; 27: 267-72.
88. Allen J, Khan S, Serrano MC, Ameer G. Characterization of porcine circulating progenitor cells: toward a functional endothelium. Tissue Eng Part A 2008; 14: 183-94.
89. Allen JB, Khan S, Lapidos KA, Ameer GA. Toward engineering a human neoendothelium with circulating progenitor cells. Stem Cells 2010; 28: 318-28.
90. Shen G, Tsung HC, Wu CF, et al. Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells. Cell Res 2003; 13: 335-41.
91. Andrews KD, Hunt JA. Upregulation of matrix and adhesion molecules induced by controlled topography. J Mater Sci Mater Med 2008; 19: 1601-8.
92. D'Amore A, Stella JA, Wagner WR, Sacks MS. Characterization of the complete fiber network topology of planar fibrous tissues and scaffolds. Biomaterials 2010; 31: 5345-54.
93. Guan J, Fujimoto KL, Wagner WR. Elastase-sensitive elastomeric scaffolds with variable anisotropy for soft tissue engineering. Pharm Res 2008; 25: 2400-12.
94. Guan J, Sacks MS, Beckman EJ, Wagner WR. Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. J Biomed Mater Res 2002; 61: 493-503.
95. Guan J, Wagner WR. Synthesis, characterization and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity. Biomacromolecules 2005; 6: 2833-42.
96. He W, Nieponice A, Soletti L, et al. Pericyte-based human tissue engineered vascular grafts. Biomaterials 2010; 31: 8235-44.
97. Nelson DM, Baraniak PR, Ma Z, Guan J, Mason NS, Wagner WR. Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold. Pharm Res 2011; 28: 1282-93.
98. Nieponice A, Soletti L, Guan J, et al. Development of a tissueengineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials 2008; 29: 825-33.
99. Wang F, Li Z, Lannutti JL, Wagner WR, Guan J. Synthesis, characterization and surface modification of low moduli poly(ether carbonate urethane)ureas for soft tissue engineering. Acta Biomater 2009; 5: 2901-12.
100. Nieponice A, Soletti L, Guan J, et al. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A 2010; 16: 1215-23.
101. McBane JE, Matheson LA, Sharifpoor S, Santerre JP, Labow RS. Effect of polyurethane chemistry and protein coating on monocyte differentiation towards a wound healing phenotype macrophage. Biomaterials 2009; 30: 5497-504.
102. McBane JE, Sharifpoor S, Cai K, Labow RS, Santerre JP. Biodegradation and in vivo biocompatibility of a degradable, polar/ hydrophobic/ionic polyurethane for tissue engineering applications. Biomaterials 2011; 32: 6034-44.
103. Sharifpoor S, Simmons CA, Labow RS, Santerre JP. Functional characterization of human coronary smooth muscle cells under cyclic mechanical strain in a degradable polyurethane scaffold. Biomaterials 2011; 32: 4816-29.
104. McBane JE, Battiston KG, Wadhwani A, Sharifpoor S, Labow RS, Santerre JP. The effect of degradable polymer surfaces on cocultures of monocytes and smooth muscle cells. Biomaterials 2011; 32: 3584-95.
105. Kumar TR, Krishnan LK. Fibrin-mediated endothelial cell adhesion to vascular biomaterials resists shear stress due to flow. J Mater Sci Mater Med 2002; 13: 751-5.
106. Fuchs S, Motta A, Migliaresi C, Kirkpatrick CJ. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials 2006; 27: 5399-408.
107. Laflamme K, Roberge CJ, Grenier G, et al. Adventitia contribution in vascular tone: insights from adventitia-derived cells in a tissueengineered human blood vessel. FASEB J 2006; 20: 1245-7.
108. Laflamme K, Roberge CJ, Labonte J, et al. Tissue-engineered human vascular media with a functional endothelin system. Circulation 2005; 111: 459-64.
109. Laflamme K, Roberge CJ, Pouliot S, et al. Tissue-engineered human vascular media produced in vitro by the self-assembly approach present functional properties similar to those of their native blood vessels. Tissue Eng 2006; 12: 2275-81.
110. Gauvin R, Ahsan T, Larouche D, et al. A novel single-step selfassembly approach for the fabrication of tissue-engineered vascular constructs. Tissue Eng Part A 2010; 16: 1737-47.
111. Nakayama Y, Ishibashi-Ueda H, Takamizawa K. In vivo tissueengineered small-caliber arterial graft prosthesis consisting of autologous tissue (biotube). Cell transplantation 2004; 13: 439-49.
112. Watanabe T, Kanda K, Ishibashi-Ueda H, Yaku H, Nakayama Y. Autologous small-caliber "biotube" vascular grafts with argatroban loading: a histomorphological examination after implantation to rabbits. J Biomed Mater Res B Appl Biomater 2010; 92: 236-42.
113. Gladish JC, Yao G, L'Heureux N, Haidekker MA. Optical transillumination tomography for imaging of tissue-engineered blood vessels. Ann Biomed Eng 2005; 33: 323-7.
114. L'Heureux N, Germain L, Auger FA. Tissue engineering. Science 1999; 284: 1621-2.
115. L'Heureux N, McAllister TN, de la Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 2007; 357: 1451-3.
116. L'Heureux N, Stoclet JC, Auger FA, Lagaud GJ, Germain L, Andriantsitohaina R. A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J 2001; 15: 515-24.
117. McAllister TN, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-6.
118. Grenier G, Remy-Zolghadri M, Bergeron F, et al. Mechanical loading modulates the differentiation state of vascular smooth muscle cells. Tissue Eng 2006; 12: 3159-70.
119. Grenier G, Remy-Zolghadri M, Guignard R, et al. Isolation and culture of the three vascular cell types from a small vein biopsy sample. In Vitro Cell Dev Biol Anim 2003; 39: 131-9.
120. Grenier G, Remy-Zolghadri M, Larouche D, et al. Tissue reorganization in response to mechanical load increases functionality. Tissue Eng 2005; 11: 90-100.
121. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002; 24: 173-83.
122. dela Paz NG, D'Amore PA. Arterial vs. venous endothelial cells. Cell Tissue Res 2009; 335: 5-16.
123. Boyer M, Townsend LE, Vogel LM, et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 2000; 31: 181-9.
124. Amabile PG, Wong H, Uy M, et al. In vivo vascular engineering of vein grafts: directed migration of smooth muscle cells by perivascular release of elastase limits neointimal proliferation. J Vasc Interv Radiol 2002; 13: 709-15.
125. Amiel GE, Komura M, Shapira O, et al. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng 2006; 12: 2355-65.
126. Cho SW, Lim JE, Chu HS, et al. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A 2006; 76: 252-63.
127. Bhattacharya V, Shi Q, Ishida A, Sauvage LR, Hammond WP, Wu MH. Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in smallcaliber synthetic vascular grafts. J Vasc Surg 2000; 32: 116-23.
128. Conklin BS, Wu H, Lin PH, Lumsden AB, Chen C. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif Organs 2004; 28: 668-75.
129. Barlis P, Regar E, Serruys PW, et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus eluting stent: a LEADERS trial sub-study. Eur Heart J 2010; 31: 165-76.
130. Wykrzykowska JJ, Onuma Y, Serruys PW. Advances in stent drug delivery: the future is in bioabsorbable stents. Expert Opin Drug Deliv 2009; 6: 113-26.
131. He W, Ma Z, Yong T, Teo WE, Ramakrishna S. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 2005; 26: 7606-15.
132. Andrews KD, Feugier P, Black RA, Hunt JA. Vascular prostheses: performance related to cell-shear responses. J Surg Res 2008; 149: 39-46.
133. Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 2005; 101: 93-109.
134. Wang C, Zhang Q, Uchida S, Kodama M. A new vascular prosthesis coated with polyamino-acid urethane copolymer (PAU) to enhance endothelialization. J Biomed Mater Res 2002; 62: 315-22.
135. Kidane AG, Punshon G, Salacinski HJ, et al. Incorporation of a lauric acid-conjugated GRGDS peptide directly into the matrix of a poly(carbonate-urea)urethane polymer for use in cardiovascular bypass graft applications. J Biomed Mater Res A 2006; 79: 606-17.
136. Fussell GW, Cooper SL. Endothelial cell adhesion on RGDcontaining methacrylate terpolymers. J Biomed Mater Res A 2004; 70: 265-73.
137. Krijgsman B, Seifalian AM, Salacinski HJ, et al. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit vs. conventional biological coatings: its role in enhancing cellular retention. Tissue Eng 2002; 8: 673-80.
138. Hubbell JA, Massia SP, Drumheller PD. Surface-grafted cellbinding peptides in tissue engineering of the vascular graft. Ann N Y Acad Sci 1992; 665: 253-8.
139. Jun HW, West JL. Endothelialization of microporous YIGSR/PEGmodified polyurethaneurea. Tissue Eng 2005; 11: 1133-40.
140. Jun HW, West J. Development of a YIGSR-peptide-modified polyurethaneurea to enhance endothelialization. J Biomater Sci Polym Ed 2004; 15: 73-94.
141. Hoffmann J, Paul A, Harwardt M, et al. Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J Biomed Mater Res A 2008; 84: 614-21.
142. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-60.
143. Lee KW, Stolz DB, Wang Y. Substantial expression of mature elastin in arterial constructs. Proc Natl Acad Sci USA 2011; 108: 2705-10.
144. Sharifpoor S, Simmons CA, Labow RS, Santerre JP. A study of vascular smooth muscle cell function under cyclic mechanical loading in a polyurethane scaffold with optimized porosity. Acta Biomater 2010; 6: 4218-28.
145. Seliktar D, Black RA, Vito RP, Nerem RM. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 2000; 28: 351-62.
146. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 2000; 19: 381-6.
147. Soletti L, Nieponice A, Guan J, Stankus JJ, Wagner WR, Vorp DA. A seeding device for tissue engineered tubular structures. Biomaterials 2006; 27: 4863-70.
148. Mironov V, Kasyanov V, Markwald RR. Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication. Trends Biotechnol 2008; 26: 338-44.
149. Hasegawa N, Yamamoto M, Imamura T, Mitsui Y, Yamamoto K. Evaluation of long-term cultured endothelial cells as a model system for studying vascular ageing. Mech Ageing Dev 1988; 46: 111-23.
150. Alobaid N, Alnaeb ME, Sales KM, Seifalian AM, Mikhailidis DP, Hamilton G. Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease. Endothelium 2005; 12: 243-50.
151. Suuronen EJ, Wong S, Kapila V, et al. Generation of CD133+ cells from CD133-peripheral blood mononuclear cells and their properties. Cardiovasc Res 2006; 70: 126-35.
152. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-8.
153. Suuronen EJ, Veinot JP, Wong S, et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 2006; 114: I138-44.
154. Kuraitis D, Hou C, Zhang Y, et al. Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. J Mol Cell Cardiol 2011; 51: 187-97.
155. Suuronen EJ, Zhang P, Kuraitis D, et al. An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 2009; 23: 1447-58.
156. Thebaud NB, Pierron D, Bareille R, Le Visage C, Letourneur D, Bordenave L. Human endothelial progenitor cell attachment to polysaccharide-based hydrogels: a pre-requisite for vascular tissue engineering. J Mater Sci Mater Med 2007; 18: 339-45.
157. Shirota T, He H, Yasui H, Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 2003; 9: 127-36.
158. Fuchs S, Hofmann A, Kirkpatrick CJ. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 2007; 13: 2577-88.
159. Ruel M, Suuronen EJ, Song J, et al. Effects of off-pump vs. onpump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. J Thorac Cardiovasc Surg 2005; 130: 633-9.
160. Hibbert B, Ma X, Pourdjabbar A, et al. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc Res 2009; 83: 16-23.
161. Ma X, Hibbert B, Dhaliwal B, et al. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor. Cardiovasc Res 2010; 86: 338-45.
162. Siepe M, Akhyari P, Lichtenberg A, Schlensak C, Beyersdorf F. Stem cells used for cardiovascular tissue engineering. Eur J Cardiothorac Surg 2008; 34: 242-7.
163. Riha GM, Lin PH, Lumsden AB, Yao Q, Chen C. Review: application of stem cells for vascular tissue engineering. Tissue Eng 2005; 11: 1535-52.
164. Liu H, Collins SF, Suggs LJ. Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials 2006; 27: 6004-14.
165. Abilez O, Benharash P, Mehrotra M, et al. A novel culture system shows that stem cells can be grown in 3D and under physiologic pulsatile conditions for tissue engineering of vascular grafts. J Surg Res 2006; 132: 170-8.
166. McCloskey KE, Gilroy ME, Nerem RM. Use of embryonic stem cell-derived endothelial cells as a cell source to generate vessel structures in vitro. Tissue Eng 2005; 11: 497-505.
167. Wu KH, Zhou B, Lu SH, et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 2007; 100: 608-16.
168. DiMuzio P, Tulenko T. Tissue engineering applications to vascular bypass graft development: the use of adipose-derived stem cells. J Vasc Surg 2007; 45 (Suppl A): A99-103.
169. Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev 2008; 4: 269-74.
170. Zuba-Surma EK, Kucia M, Ratajczak J, Ratajczak MZ. "Small stem cells" in adult tissues: very small embryonic-like stem cells stand up! Cytometry A 2009; 75: 4-13.
171. Batten P, Sarathchandra P, Antoniw JW, et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell alloresponses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng 2006; 12: 2263-73.
172. Zhang J, Qi H, Wang H, et al. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft. Artif Organs 2006; 30: 898-905.
173. Hashi CK, Zhu Y, Yang GY, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci USA 2007; 104: 11915-20.
174. Tang XJ, Wu QY. Mesenchymal stem cellular adhesion and cytotoxicity study of random biopolyester scaffolds for tissue engineering. J Mater Sci Mater Med 2006; 17: 627-32.
175. Gonda K, Shigeura T, Sato T, et al. Preserved proliferative capacity and multipotency of human adipose-derived stem cells after longterm cryopreservation. Plast Reconstr Surg 2008; 121: 401-10.
176. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009; 15: 59-68.
177. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-06.
178. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
179. Takaku M, Wada Y, Jinnouchi K, et al. An in vitro coculture model of transmigrant monocytes and foam cell formation. Arterioscler Thromb Vasc Biol 1999; 19: 2330-9.
180. Xie CQ, Huang H, Wei S, et al. A comparison of murine smooth muscle cells generated from embryonic vs. induced pluripotent stem cells. Stem Cells Dev 2009; 18: 741-8.
181. Narazaki G, Uosaki H, Teranishi M, et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008; 118: 498-506.
182. Lester EA, Babensee JE. Proinflammatory phenotype of endothelial cells after coculture with biomaterial-treated blood cells. J Biomed Mater Res A 2003; 64: 397-410.
183. Krenning G, van der Strate B, Schipper M, et al. CD34(+) cells augment endothelial cell differentiation of CD14(+) endothelial progenitor cells in vitro. J Cell Mol Med 2009; 13: 2521-33.
184. Krenning G, Dankers PY, Jovanovic D, van Luyn MJ, Harmsen MC. Efficient differentiation of CD14+ monocytic cells into endothelial cells on degradable biomaterials. Biomaterials 2007; 28: 1470-79.
185. Kuwana M, Okazaki Y, Kodama H, Satoh T, Kawakami Y, Ikeda Y. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 2006; 24: 2733-43.
186. Seta N, Kuwana M. Human circulating monocytes as multipotential progenitors. Keio J Med 2007; 56: 41-7.
187. Narita Y, Yamawaki A, Kagami H, Ueda M, Ueda Y. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res 2008; 333: 449-59.